MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

Search

Alcon Inc

Închisă

SectorSănătate

75.33 2.34

Rezumat

Modificarea prețului

24h

Curent

Minim

73.44

Maxim

75.51

Indicatori cheie

By Trading Economics

Venit

-21M

217M

Vânzări

104M

2.7B

P/E

Medie Sector

37.207

56.063

Randament dividend

0.45

Marjă de profit

7.984

Angajați

25,942

EBITDA

-144M

521M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+29.44% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.45%

2.45%

Următoarele câștiguri

4 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-4B

37B

Deschiderea anterioară

72.99

Închiderea anterioară

75.33

Sentimentul știrilor

By Acuity

50%

50%

148 / 349 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Alcon Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 mar. 2026, 14:42 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Lensar Share Slide on Terminated Merger Deal With Alcon

16 mar. 2026, 21:37 UTC

Achiziții, Fuziuni, Preluări

Lensar and Alcon Agree to Terminate Merger

6 ian. 2026, 15:11 UTC

Achiziții, Fuziuni, Preluări

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9 dec. 2025, 18:51 UTC

Achiziții, Fuziuni, Preluări

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9 dec. 2025, 15:54 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9 dec. 2025, 14:32 UTC

Achiziții, Fuziuni, Preluări

Alcon Upgrades Offer Price for Staar Surgical

16 mar. 2026, 20:59 UTC

Achiziții, Fuziuni, Preluări

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16 mar. 2026, 20:59 UTC

Achiziții, Fuziuni, Preluări

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16 mar. 2026, 20:59 UTC

Achiziții, Fuziuni, Preluări

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16 mar. 2026, 20:57 UTC

Achiziții, Fuziuni, Preluări

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

25 feb. 2026, 22:29 UTC

Achiziții, Fuziuni, Preluări

Lensar Expects to Close Transaction in 1H of 2026 >LNSR

25 feb. 2026, 22:29 UTC

Achiziții, Fuziuni, Preluări

Lensar, Alcon Continue to Cooperate With FTC in Connection With Request for Additional Info >LNSR

25 feb. 2026, 22:28 UTC

Achiziții, Fuziuni, Preluări

LENSAR Provides Update on Pending Acquisition by Alcon

24 feb. 2026, 21:41 UTC

Câștiguri

Alcon 4Q Rev $2.72B >ALC.EB

7 ian. 2026, 01:00 UTC

Achiziții, Fuziuni, Preluări

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6 ian. 2026, 22:03 UTC

Achiziții, Fuziuni, Preluări

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 ian. 2026, 22:03 UTC

Achiziții, Fuziuni, Preluări

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 ian. 2026, 15:21 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6 ian. 2026, 14:56 UTC

Achiziții, Fuziuni, Preluări

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6 ian. 2026, 14:14 UTC

Achiziții, Fuziuni, Preluări

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6 ian. 2026, 14:14 UTC

Achiziții, Fuziuni, Preluări

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6 ian. 2026, 14:14 UTC

Achiziții, Fuziuni, Preluări

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6 ian. 2026, 14:13 UTC

Achiziții, Fuziuni, Preluări

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9 dec. 2025, 14:17 UTC

Achiziții, Fuziuni, Preluări

Alcon Ups Offer Price for Staar Surgical

9 dec. 2025, 13:34 UTC

Achiziții, Fuziuni, Preluări

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9 dec. 2025, 13:33 UTC

Achiziții, Fuziuni, Preluări

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9 dec. 2025, 13:33 UTC

Achiziții, Fuziuni, Preluări

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9 dec. 2025, 13:33 UTC

Achiziții, Fuziuni, Preluări

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

9 dec. 2025, 13:32 UTC

Achiziții, Fuziuni, Preluări

Alcon: "Go-shop" Window Expired on Dec 6 >ALC.EB

9 dec. 2025, 13:32 UTC

Achiziții, Fuziuni, Preluări

Alcon: Transaction Now Represents Total Equity Value of About $1.6B >ALC

Comparație

Modificare preț

Alcon Inc Așteptări

Obiectiv de preț

By TipRanks

29.44% sus

Prognoză pe 12 luni

Medie 95.36 USD  29.44%

Maxim 118.981 USD

Minim 75.146 USD

În baza a 14 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAlcon Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

14 ratings

9

Cumpărare

4

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

95.77 / 97.61Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Strong Bullish Evidence

Sentiment

By Acuity

148 / 349 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat